Diagnostic Kits/Data, narratives and tools produced by the Kits' sector: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 17: Line 17:
|-
|-
!Gene
!Gene
!
!BRCA1
|-
|-
|Patent Holders
|Patent Holders
|
|Myriad Genetics
|-
|-
|Key Patents
|Key Patents
|
|5753441, 6051379
|-
|-
|Other Patents
|Other Patents
Line 29: Line 29:
|-
|-
|Licenses
|Licenses
|
|exclusive
|-
|-
|US Test providers
|US Test providers
|
|1
|-
|Test cost
|
|}
 
 
 
 
{|
|-
|-
!Gene
|Test
!
|BRACAnalysis ($3120) - includes BRCA1 & BRCA2
|-
|Patent Holders
|
|-
|Key Patents
|
|-
|Other Patents
|
|-
|Licenses
|
|-
|US Test providers
|
|-
|-
|Test cost
|Test cost
|
|$3120
|}
|}


Revision as of 18:13, 23 November 2009

Types of inputs for kits

Genetic Diagnostic Case Studies

The following are summaries of IP and commercialization information of commercially available diagnostic kits. A subset of this list will be developed into more extensive case studies. The old spreadsheet form of this information is available here.

Breast and Ovarian Cancer

BRCA1

  • Patent Holders
    Myriad Genetics (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Gene BRCA1
Patent Holders Myriad Genetics
Key Patents 5753441, 6051379
Other Patents
Licenses exclusive
US Test providers 1
Test BRACAnalysis ($3120) - includes BRCA1 & BRCA2
Test cost $3120

BRCA2

  • Patent Holders
    Myriad Genetics (exclusive licensee)
  • key patents
    5753441, 6051379,
  • products
    BRACAnalysis ($3120) - includes BRCA1 & BRCA2

References

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Data,_narratives_and_tools_produced_by_the_Kits%27_sector&oldid=5395"